EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overview of the DREADDs chemogenetics and the patent landscape of their actuators

Subhradeep Dutta, Malliga R Iyer

Medicinal Chemistry Research · 2026

DOI: 10.1007/s00044-026-03585-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Chemistry Research, 2026. Verfasst von Subhradeep Dutta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD, …. Hauptthemen laut MEDLINE: Chemogenetics, Designer Drugs, Patents as Topic, Receptors, G-Protein-Coupled. Die Arbeit nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability to manipulate specific neural populations with high temporal and spatial precision has revolutionized our understanding of brain-behavior relationships. Among the most versatile tools in the chemogenetic arsenal are Designer Receptors Exclusively Activated by Designer Drugs (DREADDs). By introducing engineered proteins that remain inert to endogenous neurotransmitters but react potently to synthetic actuators, chemogenetics provides unparalleled control over neural circuits in vivo. With the field evolving, new designer ligands and designer receptors have been reported. This review provides an update on the latest advances in DREADD chemogenetics, focusing on the development of next-generation ligands and the patent landscape innovations driving the next era of precision neuromodulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChemogeneticsDesigner DrugsPatents as TopicReceptors, G-Protein-CoupledHumansAnimalsLigands

Stichwörter der Autor:innen

ChemogeneticsClozapine N-oxideDREADDsGPCRsNeural CircuitsNeuromodulation

Substanzen

Designer DrugsLigandsReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD, 20852, USA.
  • Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD, 20852, USA. malliga.iyer@nih.gov.

Förderung

  • NIAAA NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Dutta, S., & Iyer, M. R. (2026). Overview of the DREADDs chemogenetics and the patent landscape of their actuators. Medicinal Chemistry Research. https://doi.org/10.1007/s00044-026-03585-8

Vancouver

Dutta S, Iyer MR. Overview of the DREADDs chemogenetics and the patent landscape of their actuators. Medicinal Chemistry Research. 2026. doi:10.1007/s00044-026-03585-8

BibTeX
@article{Dutta2026,
  author = {Dutta, Subhradeep and Iyer, Malliga R},
  title = {Overview of the DREADDs chemogenetics and the patent landscape of their actuators},
  journal = {Medicinal Chemistry Research},
  year = {2026},
  doi = {10.1007/s00044-026-03585-8}
}
Kostenlos starten →